Hans Jonsson
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Hans Jonsson has a total of 57 co-authors. Here are the top co-authors by number of shared publications:
- Stefan Roos
Department of Molecular Sciences, Uppsala BioCenter, Swedish University of Agricultural Sciences, 750 07 Uppsala, Sweden
12 shared publications Stefan Roos
Department of Microbiology , Swedish University of Agricultural Sciences , Uppsala, Sweden
5 shared publications- Bengt Guss
Department of Animal Biosciences, Swedish University of Agricultural Sciences, 750 07 Uppsala, Sweden
3 shared publications Martin Lindberg
Swedish University of Agricultural Sciences, SLU, Department of Microbiology, Box 7025, S-75007 Uppsala, Sweden
3 shared publicationsRobert A. Britton
Department of Microbiology and Molecular Genetics, Michigan State University, East Lansing, MI 48824, USA
3 shared publicationsTorun Wall
Department of Microbiology, Swedish University of Agricultural Sciences, Box 7025, SE-750 07 Uppsala, Sweden, and Department of Pathology, Texas Children's Hospital, Houston, TX 77030, USA
3 shared publications
Latest Publications
- Open Access
- 4 September 2020
- Published by Springer Nature in Communications Biology
- Vol. 3 (1) , 1-9
Genome sequence of segmented filamentous bacteria present in the human intestine
Segmented filamentous bacteria (SFB) are unique immune modulatory bacteria colonizing the small intestine of a variety of animals in a host-specific manner. SFB exhibit filamentous growth and attach to the host’s intestinal epithelium, offering a physical route of interaction. SFB affect functions of the host immune system, among them IgA production and T-cell maturation. Until now, no human-specific SFB genome has been reported. Here, we report the metagenomic reconstruction of an SFB genome from a human ileostomy sample. Phylogenomic analysis clusters the genome with SFB genomes from mouse, rat and turkey, but the genome is genetically distinct, displaying 65–71% average amino acid identity to the others. By screening human faecal metagenomic datasets, we identified individuals carrying sequences identical to the new SFB genome. We thus conclude that a unique SFB variant exists in humans and foresee a renewed interest in the elucidation of SFB functionality in this environment.
- 4 September 2020
- Published by Springer Nature in Communications Biology
- Vol. 3 (1) , 1-9
Open AccessGenome sequence of segmented filamentous bacteria present in the human intestine
Segmented filamentous bacteria (SFB) are unique immune modulatory bacteria colonizing the small intestine of a variety of animals in a host-specific manner. SFB exhibit filamentous growth and attach to the host’s intestinal epithelium, offering a physical route of interaction. SFB affect functions of the host immune system, among them IgA production and T-cell maturation. Until now, no human-specific SFB genome has been reported. Here, we report the metagenomic reconstruction of an SFB genome from a human ileostomy sample. Phylogenomic analysis clusters the genome with SFB genomes from mouse, rat and turkey, but the genome is genetically distinct, displaying 65–71% average amino acid identity to the others. By screening human faecal metagenomic datasets, we identified individuals carrying sequences identical to the new SFB genome. We thus conclude that a unique SFB variant exists in humans and foresee a renewed interest in the elucidation of SFB functionality in this environment.
- Open Access
Genome Sequence of Segmented Filamentous Bacteria Present in the Human Intestine
Summary: Segmented filamentous bacteria (SFB) colonize the small intestine of a variety of animals in a host-specific manner. SFB are physically attached to the host’s intestinal epithelium and affect several functions related to the immune system, among them IgA production and T-cell maturation. Until now, no human-specific SFB genome had been described. Here, we report the metagenomic reconstruction of an SFB genome from a human ileostomy sample. Phylogenomic analysis clusters the genome with the SFB genomes from mouse, rat and turkey, but the genome is genetically distinct, displaying 65-71% average amino acid identity to the other genomes, and is tentatively unique for the human small intestine. By screening human faecal metagenomic datasets, we identified individuals carrying sequences identical to the new SFB-genome. We thus conclude that a unique SFB variant exists in humans and we foresee a renewed interest in the elucidation of SFB functionality in this environment.
Open AccessGenome Sequence of Segmented Filamentous Bacteria Present in the Human Intestine
Summary: Segmented filamentous bacteria (SFB) colonize the small intestine of a variety of animals in a host-specific manner. SFB are physically attached to the host’s intestinal epithelium and affect several functions related to the immune system, among them IgA production and T-cell maturation. Until now, no human-specific SFB genome had been described. Here, we report the metagenomic reconstruction of an SFB genome from a human ileostomy sample. Phylogenomic analysis clusters the genome with the SFB genomes from mouse, rat and turkey, but the genome is genetically distinct, displaying 65-71% average amino acid identity to the other genomes, and is tentatively unique for the human small intestine. By screening human faecal metagenomic datasets, we identified individuals carrying sequences identical to the new SFB-genome. We thus conclude that a unique SFB variant exists in humans and we foresee a renewed interest in the elucidation of SFB functionality in this environment.
- Open Access
- 25 January 2018
- Published by Wiley in Physiological Reports
- Vol. 6 (2) , e13514
Lactobacillus reuteristrains protect epithelial barrier integrity of IPEC-J2 monolayers from the detrimental effect of enterotoxigenicEscherichia coli
Lactobacillus reuteri is an inhabitant of the gastrointestinal (GI) tract of mammals and birds and several strains of this species are known to be effective probiotics. The mechanisms by which L. reuteri confers its health-promoting effects are far from being fully understood, but protection of the mucosal barrier is thought to be important. Leaky gut is a state of abnormal intestinal permeability with implications for the pathophysiology of various gastrointestinal disorders. Enterotoxigenic Escherichia coli (ETEC) can invade the intestinal mucosa and induce changes in barrier function by producing enterotoxin or by direct invasion of the intestinal epithelium. Our hypothesis was that L. reuteri can protect the mucosal barrier, and the goal of the study was to challenge this hypothesis by monitoring the protective effect of L. reuteri strains on epithelial dysfunction caused by ETEC. Using an infection model based on the porcine intestinal cell line IPEC-J2, it was demonstrated that pretreatment of the cells with human-derived L. reuteri strains (ATCC PTA 6475, DSM 17938 and 1563F) and a rat strain (R2LC) reduced the detrimental effect of ETEC in a dose-dependent manner, as monitored by permeability of FITC-dextran and transepithelial electrical resistance (TEER). Moreover, the results revealed that ETEC upregulated proinflammatory cytokines IL-6 and TNFα and decreased expression of the shorter isoform of ZO-1 (187 kDa) and E-cadherin. In contrast, pretreatment with L. reuteri DSM 17938 and 1563F downregulated expression of IL-6 and TNFα, and led to an increase in production of the longer isoform of ZO-1 (195 kDa) and maintained E-cadherin expression. Interestingly, expression of ZO-1 (187 kDa) was preserved only when the infected cells were pretreated with strain 1563F. These findings demonstrate that L. reuteri strains exert a protective effect against ETEC-induced mucosal integrity disruption.
- 25 January 2018
- Published by Wiley in Physiological Reports
- Vol. 6 (2) , e13514
Open AccessLactobacillus reuteristrains protect epithelial barrier integrity of IPEC-J2 monolayers from the detrimental effect of enterotoxigenicEscherichia coli
Lactobacillus reuteri is an inhabitant of the gastrointestinal (GI) tract of mammals and birds and several strains of this species are known to be effective probiotics. The mechanisms by which L. reuteri confers its health-promoting effects are far from being fully understood, but protection of the mucosal barrier is thought to be important. Leaky gut is a state of abnormal intestinal permeability with implications for the pathophysiology of various gastrointestinal disorders. Enterotoxigenic Escherichia coli (ETEC) can invade the intestinal mucosa and induce changes in barrier function by producing enterotoxin or by direct invasion of the intestinal epithelium. Our hypothesis was that L. reuteri can protect the mucosal barrier, and the goal of the study was to challenge this hypothesis by monitoring the protective effect of L. reuteri strains on epithelial dysfunction caused by ETEC. Using an infection model based on the porcine intestinal cell line IPEC-J2, it was demonstrated that pretreatment of the cells with human-derived L. reuteri strains (ATCC PTA 6475, DSM 17938 and 1563F) and a rat strain (R2LC) reduced the detrimental effect of ETEC in a dose-dependent manner, as monitored by permeability of FITC-dextran and transepithelial electrical resistance (TEER). Moreover, the results revealed that ETEC upregulated proinflammatory cytokines IL-6 and TNFα and decreased expression of the shorter isoform of ZO-1 (187 kDa) and E-cadherin. In contrast, pretreatment with L. reuteri DSM 17938 and 1563F downregulated expression of IL-6 and TNFα, and led to an increase in production of the longer isoform of ZO-1 (195 kDa) and maintained E-cadherin expression. Interestingly, expression of ZO-1 (187 kDa) was preserved only when the infected cells were pretreated with strain 1563F. These findings demonstrate that L. reuteri strains exert a protective effect against ETEC-induced mucosal integrity disruption.
- 1 August 2016
- Published by Elsevier in Food Microbiology
- Vol. 57, 159-171
Evaluation of growth, metabolism and production of potentially bioactive components during fermentation of barley with Lactobacillus reuteri
- 1 August 2016
- Published by Elsevier in Food Microbiology
- Vol. 57, 159-171
Evaluation of growth, metabolism and production of potentially bioactive components during fermentation of barley with Lactobacillus reuteri
- Open Access
- 1 April 2014
- Published by Microbiology Society in Microbiology
- Vol. 160 (4) , 671-681
Role of Lactobacillus reuteri cell and mucus-binding protein A (CmbA) in adhesion to intestinal epithelial cells and mucus in vitro
Lactobacillus reuteri, a symbiotic inhabitant of the gastrointestinal tract in humans and animals, is marketed as a probiotic. The ability to adhere to intestinal epithelial cells and mucus is an interesting property with regard to probiotic features such as colonization of the gastrointestinal tract and interaction with the host. Here, we present a study performed to elucidate the role of sortase (SrtA), four putative sortase-dependent proteins (SDPs), and one C-terminal membrane-anchored cell surface protein ofLactobacillus reuteriATCC PTA 6475 in adhesion to Caco-2 cells and mucusin vitro. This included mutagenesis of the genes encoding these proteins and complementation of mutants. A null mutation inhmpref0536_10255encodingsrtAresulted in significantly reduced adhesion to Caco-2 cells and mucus, indicating involvement of SDPs in adhesion. Evaluation of the bacterial adhesion revealed that of the five putative surface protein mutants tested, only a null mutation in thehmpref0536_10633gene, encoding a putative SDP with an LPxTG motif, resulted in a significant loss of adhesion to both Caco-2 cells and mucus. Complementation with the functional gene on a plasmid restored adhesion to Caco-2 cells. However, complete restoration of adhesion to mucus was not achieved. Overexpression ofhmpref0536_10633in strain ATCC PTA 6475 resulted in an increased adhesion to Caco-2 cells and mucus compared with the WT strain. We conclude from these results that, among the putative surface proteins tested, the protein encoded byhmpref0536_10633plays a critical role in binding ofLactobacillus reuteriATCC PTA 6475 to Caco-2 cells and mucus. Based on this, we propose that this LPxTG motif containing protein should be referred to as cell and mucus binding protein A (CmbA).
- 1 April 2014
- Published by Microbiology Society in Microbiology
- Vol. 160 (4) , 671-681
Open AccessRole of Lactobacillus reuteri cell and mucus-binding protein A (CmbA) in adhesion to intestinal epithelial cells and mucus in vitro
Lactobacillus reuteri, a symbiotic inhabitant of the gastrointestinal tract in humans and animals, is marketed as a probiotic. The ability to adhere to intestinal epithelial cells and mucus is an interesting property with regard to probiotic features such as colonization of the gastrointestinal tract and interaction with the host. Here, we present a study performed to elucidate the role of sortase (SrtA), four putative sortase-dependent proteins (SDPs), and one C-terminal membrane-anchored cell surface protein ofLactobacillus reuteriATCC PTA 6475 in adhesion to Caco-2 cells and mucusin vitro. This included mutagenesis of the genes encoding these proteins and complementation of mutants. A null mutation inhmpref0536_10255encodingsrtAresulted in significantly reduced adhesion to Caco-2 cells and mucus, indicating involvement of SDPs in adhesion. Evaluation of the bacterial adhesion revealed that of the five putative surface protein mutants tested, only a null mutation in thehmpref0536_10633gene, encoding a putative SDP with an LPxTG motif, resulted in a significant loss of adhesion to both Caco-2 cells and mucus. Complementation with the functional gene on a plasmid restored adhesion to Caco-2 cells. However, complete restoration of adhesion to mucus was not achieved. Overexpression ofhmpref0536_10633in strain ATCC PTA 6475 resulted in an increased adhesion to Caco-2 cells and mucus compared with the WT strain. We conclude from these results that, among the putative surface proteins tested, the protein encoded byhmpref0536_10633plays a critical role in binding ofLactobacillus reuteriATCC PTA 6475 to Caco-2 cells and mucus. Based on this, we propose that this LPxTG motif containing protein should be referred to as cell and mucus binding protein A (CmbA).
- Open Access
- 28 February 2013
- Published by Oxford University Press (OUP) in FEMS Microbiology Letters
- Vol. 342 (1) , 24-29
Segmented filamentous bacteria in human ileostomy samples after high-fiber intake
Segmented filamentous bacteria (SFB) are inhabitants of the small intestine of various animals, where they can be detected microscopically due to the
- 28 February 2013
- Published by Oxford University Press (OUP) in FEMS Microbiology Letters
- Vol. 342 (1) , 24-29
Open AccessSegmented filamentous bacteria in human ileostomy samples after high-fiber intake
Segmented filamentous bacteria (SFB) are inhabitants of the small intestine of various animals, where they can be detected microscopically due to the
- 1 April 2011
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 55 (4) , 1622-1628
Lactobacilli Reduce Cell Cytotoxicity Caused by Streptococcus pyogenes by Producing Lactic Acid That Degrades the Toxic Component Lipoteichoic Acid
Lactobacilli are known to prevent colonization by many pathogens; nevertheless, the mechanisms of their protective effect are largely unknown. In this work, we investigated the role of lactobacilli during infection of epithelial cells with group A ...
- 1 April 2011
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 55 (4) , 1622-1628
Lactobacilli Reduce Cell Cytotoxicity Caused by Streptococcus pyogenes by Producing Lactic Acid That Degrades the Toxic Component Lipoteichoic Acid
Lactobacilli are known to prevent colonization by many pathogens; nevertheless, the mechanisms of their protective effect are largely unknown. In this work, we investigated the role of lactobacilli during infection of epithelial cells with group A ...
- 1 October 2008
- Published by Elsevier in Systematic and Applied Microbiology
- Vol. 31 (5) , 323-338
Global transcriptional response of Lactobacillus reuteri to the sourdough environment
- 1 October 2008
- Published by Elsevier in Systematic and Applied Microbiology
- Vol. 31 (5) , 323-338
Global transcriptional response of Lactobacillus reuteri to the sourdough environment
- 1 October 2008
- Published by Elsevier in Microbes and Infection
- Vol. 10 (12-13) , 1325-1334
Adherence of clinically isolated lactobacilli to human cervical cells in competition with Neisseria gonorrhoeae
- 1 October 2008
- Published by Elsevier in Microbes and Infection
- Vol. 10 (12-13) , 1325-1334
Adherence of clinically isolated lactobacilli to human cervical cells in competition with Neisseria gonorrhoeae
- 15 June 2007
- Published by American Society for Microbiology in Applied and Environmental Microbiology
- Vol. 73 (12) , 3924-3935
The Early Response to Acid Shock inLactobacillus reuteriInvolves the ClpL Chaperone and a Putative Cell Wall-Altering Esterase
To be able to function as a probiotic, bacteria have to survive the passage through the gastrointestinal tract. We have examined survival and gene expression ofLactobacillus reuteriATCC 55730 after a sudden shift in environmental acidity to a pH close to the conditions in the human stomach. More than 80% of theL. reutericells survived at pH 2.7 for 1 h. A genomewide expression analysis experiment using microarrays displayed 72 differentially expressed genes at this pH. The early response to severe acid shock inL. reuteridiffered from long-term acid adaptation to milder acid stress studied in other lactic acid bacteria. The genes induced included the following:clpL, genes putatively involved in alterations of the cell membrane and the cell wall; genes encoding transcriptional regulators; phage genes; and genes of unknown function. Two genes,clpL, encoding an ATPase with chaperone activity, and lr1516, encoding a putative esterase, were selected for mutation analyses. The mutants were significantly more sensitive to acid than the wild type was. Thus, these genes could contribute to the survival ofL. reuteriin the gastrointestinal tract.
- 15 June 2007
- Published by American Society for Microbiology in Applied and Environmental Microbiology
- Vol. 73 (12) , 3924-3935
The Early Response to Acid Shock inLactobacillus reuteriInvolves the ClpL Chaperone and a Putative Cell Wall-Altering Esterase
To be able to function as a probiotic, bacteria have to survive the passage through the gastrointestinal tract. We have examined survival and gene expression ofLactobacillus reuteriATCC 55730 after a sudden shift in environmental acidity to a pH close to the conditions in the human stomach. More than 80% of theL. reutericells survived at pH 2.7 for 1 h. A genomewide expression analysis experiment using microarrays displayed 72 differentially expressed genes at this pH. The early response to severe acid shock inL. reuteridiffered from long-term acid adaptation to milder acid stress studied in other lactic acid bacteria. The genes induced included the following:clpL, genes putatively involved in alterations of the cell membrane and the cell wall; genes encoding transcriptional regulators; phage genes; and genes of unknown function. Two genes,clpL, encoding an ATPase with chaperone activity, and lr1516, encoding a putative esterase, were selected for mutation analyses. The mutants were significantly more sensitive to acid than the wild type was. Thus, these genes could contribute to the survival ofL. reuteriin the gastrointestinal tract.